Cornell University

Early assessment, drug switch improves cancer treatment

Metastatic prostate cancer patients respond better to treatment when they switch to different drugs in the absence of an optimal initial response, according to new research from Weill Cornell Medicine and NewYork-Presbyterian.

Jun 07, 2016
popularity3 comments 0

Immunotherapy treats aggressive form of lymphoma

A drug that recruits immune cells to fight an aggressive form of lymphoma that disproportionately affects minorities in the United States appears to be more effective than chemotherapy, according to new research from Weill ...

Jun 07, 2016
popularity4 comments 0

New method reveals possible prostate cancer therapy

The steroid dexamethasone could potentially deter the growth of a prostate cancer subtype that was previously thought to be difficult to treat with medications, Weill Cornell Medicine researchers report. Their findings were ...

Jun 06, 2016
popularity35 comments 0